Press release
Autologous Stem Cell And Non-Stem Cell Based Therapies Market Trends That Will Shape the Next Decade: Insights from Advancements In Autologous T-cell Immunotherapy
Autologous Stem Cell And Non-Stem Cell Based Therapies Market
How Large Will the Autologous Stem Cell And Non-Stem Cell Based Therapies Market Size By 2025?
There has been a swift expansion in the market size of autologous stem cell and non-stem cell based therapies in the last few years. It is projected to increase from $9.96 billion in 2024 to $11.49 billion in 2025, marking a compound annual growth rate (CAGR) of 15.5%. Factors such as the growing incidence of cancer and diabetes, an increasing geriatric population, heightened awareness about healthcare, a surge in research and development activities, a rise in clinical trials, and more regulatory approvals have largely contributed to this growth during the historic period.
How Big Is the Autologous Stem Cell And Non-Stem Cell Based Therapies Market Size Expected to Grow by 2029?
The market size for autologous stem cell and non-stem cell based therapies is predicted to experience significant growth in the forthcoming years. It is projected to escalate to "$20.07 billion by 2029 with a compound annual growth rate (CAGR) of 15.0%. The surge during the forecast period can be associated with factors such as the escalating incidence of specific diseases, the growing older population, the increasing frequency of neurodegenerative diseases, the rising number of cancer incidents, the heightened demand for skin transplants, greater awareness of regenerative medicine, and collaborations and partnerships among leading entities. The reimbursement for approved therapies is also getting better. Major trends during this forecast period encompass the incorporation of artificial intelligence and machine learning, the creation of ready-to-use allogeneic stem cell products, the enlargement of reimbursement policies, the adaptation of innovative biomaterials, advances in cell production technologies, the acceptance of autologous stem cell therapies, and the incorporation of gene editing technologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/autologous-stem-cell-and-non-stem-cell-based-therapies-global-market-report
Which Key Market Drivers Powering Autologous Stem Cell And Non-Stem Cell Based Therapies Market Expansion and Growth?
The growth of the autologous stem cell and non-stem cell-based therapies market is suspected to be bolstered by the increasing demand for personalized therapies. These treatments are developed to optimize benefits and decrease adverse consequences, taking into account a patient's unique genetic makeup, lifestyle, and preferences. Numerous factors, including advancements in genetics and technology which facilitate more accurate and successful treatments with fewer side effects, a rise in patient requests for personalized healthcare, and the possibility of reducing healthcare costs, are driving these personalized therapies. Customizing autologous stem cell and non-stem cell-based therapies to match a person's distinctive genetic and health traits improves their application, leading to superior results and reduced complications. For example, the Personalized Medicine Coalition, a professional membership organization in the US, noted that in 2022, 12 newly approved personalized medicines made up approximately 34% of all newly approved treatments. This represents a significant leap from previous years. For these reasons, the desire for personalized therapies is a major growth influencer for the autologous stem cell and non-stem cell-based therapies market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15729&type=smp
What Long-Term Trends Will Define the Future of the Autologous Stem Cell And Non-Stem Cell Based Therapies Market?
Leading businesses in the autologous stem cell and non-stem cell-based therapies market are advancing autologous T cell immunotherapy derived from tumors to improve personalized methods for cancer treatment. This type of immunotherapy involves extracting T cells from a patient's tumor, cultivating and activating them in a lab, and then reintroducing them back into the patient to strengthen their immune system's capability to specifically identify and eliminate cancer cells. For example, in February 2024, Iovance Biotherapeutics, an American biotechnology firm, gained expedited approval from the US-based Food and Drug Administration for Amtagvi (lifileucel), which marks the first cellular therapy prescribed for treating adult patients suffering from melanoma. Lifileucel, a immunotherapy based on autologous T-cells derived from tumors, consists of the patient's naturally occurring immune cells known as tumor-infiltrating lymphocytes (TILs). This enhances the immune system's ability of the patient to effectively recognize and combat the cancer.
What Are the Emerging Segments in the Autologous Stem Cell And Non-Stem Cell Based Therapies Market?
The autologous stem cell and non-stem cell based therapies market covered in this report is segmented -
1) By Type: Autologous Stem Cells, Autologous Non-Stem Cells, Other Types
2) By Application: Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Research Facilities, Other End Users
Subsegments:
1) By Autologous Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Neural Stem Cells, Endothelial Stem Cells
2) By Autologous Non-Stem Cells: Platelet-Rich Plasma (Prp), Adipose-Derived Cells, Peripheral Blood Cells
3) By Other Types: Exosome-Based Therapies, Tissue-Engineered Constructs
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15729&type=smp
Who Are the Global Leaders in the Autologous Stem Cell And Non-Stem Cell Based Therapies Market?
Major companies operating in the autologous stem cell and non-stem cell based therapies market are Bayer AG, Novartis AG, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck & Co. Inc., Stemcell Technologies Inc., Dendreon Corporation, Vericel Corporation, Sangamo Therapeutics Inc., NEOSTEM, Orgenesis Inc., Adaptimmune Therapeutics, Stempeutics Research Pvt Ltd., MEDIPOST, Castle Creek Biosciences Inc., BrainStorm Cell Limited, Athersys Inc., Cytori Therapeutics Inc., Opexa Therapeutics, Gamida Cell, Regen BioPharma Inc., RepliCel Life Sciences, InGeneron Inc., BioCardia Inc., ReNeuron Group
Which are the Top Profitable Regional Markets for the Autologous Stem Cell And Non-Stem Cell Based Therapies Industry?
North America was the largest region in the autologous stem cell and non-stem cell based therapies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autologous stem cell and non-stem cell based therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15729
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autologous Stem Cell And Non-Stem Cell Based Therapies Market Trends That Will Shape the Next Decade: Insights from Advancements In Autologous T-cell Immunotherapy here
News-ID: 4182438 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
